the genetic landscape of mds: how this is improving & impacting the development of therapies
Published 8 months ago • 43 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
3:56
the genetic landscape of mds and impact on treatment
-
1:27
the impact of inflammation & the microenvironment in the development and progression of mds
-
2:40
the importance of studying the genetic landscape of myeloid malignancies
-
1:30
genomics: mds pathology & treatment
-
1:36
insights into the biology of pediatric mds
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
7:54
patient/caregiver stories - living with mds
-
3:54
life with mds: jill shares how her family helped her overcome an mds diagnosis
-
19:12
an approach to diagnosis and staging of mds: from morphology to genetics
-
1:16
state of the art: mds
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
1:41
an overview of the mds diagnosis pathway
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
4:01
the latest genomic updates in the field of mds
-
1:51
factors driving the transformation of chip to mds
-
1:55
mds genomics: diagnosis and prognosis
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
0:35
mds: the role of the multidisciplinary team
-
1:18
incorporating genetic analyses in the diagnostic pathway of mds
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:01
evolving role of next-generation sequencing in mds
-
1:50
germline predispositions in myelodysplastic syndromes (mds) and acute myeloid leukemia (aml)